Literature DB >> 14617444

Alcohol use self report in chronic back pain--relationships to psychosocial factors, function performance, and medication use.

Ethan A Booker1, Andrew J Haig, Michael E Geisser, Karen Yamakawa.   

Abstract

BACKGROUND CONTEXT: Alcohol consumption is a known risk factor for spinal disability, but there is no data on the relationship between reported alcohol consumption and behaviours in persons who are disabled.
PURPOSE: To determine the interaction between reported alcohol consumption, physical performance, and medication use in this group. To determine psychosocial correlates of reported alcohol consumption in this group.
METHODS: A retrospective review 147 men and 136 women with more than 3 months disability who underwent a multidisciplinary physical, functional and psychosocial Spine Team Assessment. Questions about alcohol consumption were related to outcome measures.
RESULTS: None of the women reported more than 5 drinks/week. Ten men reported more than 12 drinks per week. These performed significantly better on the Progressive Isoinertial Lifting Evaluation (PILE) low lift and the Functional Assessment Screening Test (FAST) 5 minute twisting test, and trended towards better performance on all other tests (the PILE high lift, all 4 other FAST components, Sorenson trunk extension test, and bicycle ergometer submaximal stress test). They had less back pain disability (Quebec p = 0.061), but no difference in depression (CESD), pain (visual analog scale) or fear (Tampa). They used fewer Non-steroidal medications, but similar narcotic medications as the others. No significant differences in the SF-36 were noted.
CONCLUSIONS: This first assessment of the relationship of alcohol consumption with back pain disability suggests that women with chronic back pain disability seldom report heavy alcohol consumption. Men with back pain disability who consume large amounts of alcohol have less physical disability despite similar pain. Despite potential interactions, heavy drinkers with pain do not use fewer narcotic analgesics than light drinkers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617444     DOI: 10.1080/09638280310001608609

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  7 in total

Review 1.  Interrelations between pain and alcohol: An integrative review.

Authors:  Emily L Zale; Stephen A Maisto; Joseph W Ditre
Journal:  Clin Psychol Rev       Date:  2015-02-25

2.  Painful medical conditions and alcohol use: a prospective study among older adults.

Authors:  Penny L Brennan; Kathleen K Schutte; Sonya SooHoo; Rudolf H Moos
Journal:  Pain Med       Date:  2011-06-13       Impact factor: 3.750

3.  Mechanisms controlling theophylline release from ethanol-resistant coated pellets.

Authors:  Y Rosiaux; C Velghe; S Muschert; R Chokshi; B Leclercq; F Siepmann; J Siepmann
Journal:  Pharm Res       Date:  2013-09-26       Impact factor: 4.200

4.  Association between physical pain and alcohol treatment outcomes: The mediating role of negative affect.

Authors:  Katie Witkiewitz; Elizabeth McCallion; Kevin E Vowles; Megan Kirouac; Tessa Frohe; Stephen A Maisto; Ray Hodgson; Nick Heather
Journal:  J Consult Clin Psychol       Date:  2015-06-22

5.  Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial.

Authors:  Katie Witkiewitz; Kevin E Vowles; Elizabeth McCallion; Tessa Frohe; Megan Kirouac; Stephen A Maisto
Journal:  Addiction       Date:  2015-06-03       Impact factor: 6.526

6.  Self-report of alcohol use for pain in a multi-ethnic community sample.

Authors:  Joseph L Riley; Christopher King
Journal:  J Pain       Date:  2009-09       Impact factor: 5.820

7.  Association between alcohol consumption and symptom severity and quality of life in patients with fibromyalgia.

Authors:  Chul H Kim; Ann Vincent; Daniel J Clauw; Connie A Luedtke; Jeffrey M Thompson; Terry D Schneekloth; Terry H Oh
Journal:  Arthritis Res Ther       Date:  2013-03-15       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.